Marker may predict response to ipilimumab in advanced melanoma
Among patients with advanced melanoma, presence of higher levels of the protein vascular endothelial growth factor (VEGF) in blood was associated with poor response to treatment with the immunotherapy ipilimumab, according ...
Feb 4, 2014
0
0